Liven Pharma Limited - LIVEN

Rs 45.10

Change -1.39

On Jan 30

Trades end of day

Last trade on Jan 30, 2026 Day's range Rs 44.71 - 46.49
Change Rs -1.39 52 week range Rs 44.71 - 162.00
Open Rs 46.49 Volume 72,129
Close Rs 45.10 Previous Close Rs 45.10

LIVEN Company Meetings

No Meetings
 

LIVEN Trade Activity

Period High Low Volume
1M 53.56 45.10 2,817,034.00; Avg 128,047.00
3M 67.10 45.10 13,705,344.00; Avg 214,146.00
6M 71.31 45.10 31,070,936.00; Avg 240,859.97
1Y 151.30 45.10 85,520,226.00; Avg 343,454.72
 
 

Latest Annual Financials

Financial Year O/S Shares 0.00m
Net Profit Rs 0.00m Market Cap Rs 0.00m
EPS 0.00 P/E 0.00
Par Value Rs 0.00 Book Value 0.00
Net Worth Rs 0.00m Outstanding Shares 0.00m
Dividend Rs 0.00 ROE 0.00%
Dividend Yield 0.00% Divident Payout 0.00%
Earnings Yield 0.00% Sharia No
 

Price Chart

Yasir Mahmood Securities has partnered with TradingView for its charting solution.
A comprehensive trading platform which offers intuitive analytical tools, stock screener and real time economic calendar data to track key financial events.

 

The company is in the Pharmaceuticals sector.

 

Other Companies in This Sector

Company Current Change Date
Abbot Laboratories Rs 1,154.39 -0.40% Jan 30, 2026
AGP Limited Rs 210.71 0.63% Jan 30, 2026
BF Biosciences Limited Rs 156.42 0.27% Jan 30, 2026
Citi Pharma Limited Rs 85.87 0.72% Jan 30, 2026
Ferozsons Laboratories Limited Rs 432.19 -0.42% Jan 30, 2026
Glaxosmithkline Rs 419.79 0.19% Jan 30, 2026
Glaxo Healthcare Pakistan Rs 120.23 -3.20% Jan 30, 2023
Haleon Pakistan Limited Rs 940.06 -0.52% Jan 30, 2026
Highnoon Laboratories Rs 1,010.47 -1.41% Jan 30, 2026
Hoechst Pakistan Limited Rs 4,435.34 -0.31% Jan 30, 2026
IBL Healthcare Limited Rs 57.85 -0.26% Jan 30, 2026
IBL Healthcare Limited (r) Rs 0.00 0.00% Jan 31, 2026
Liven Pharma Limited Rs 45.10 -2.99% Jan 30, 2026
Liven Pharma Limited (r) Rs 0.00 0.00% Jan 31, 2026
Macter International Limited Rs 339.26 -0.80% Jan 30, 2026
 

Shareholding Pattern

Year Individual Institutions Investment Companies Foreign Investors Government Shareholders Other